Cardiovascular Therapeutics

Cardiovascular Therapeutics

心血管治疗

  • 4区 中科院分区
  • Q2 JCR分区

期刊简介

《Cardiovascular Therapeutics》是由Wiley-Blackwell Publishing Ltd出版社于2008年创办的英文国际期刊(ISSN: 1755-5914,E-ISSN: 1755-5922),该期刊长期致力于药学领域的创新研究,主要研究方向为医学-心血管系统。作为SCIE收录期刊(JCR分区 Q2,中科院 4区),本刊采用OA未开放获取模式(OA占比0.3590...%),以发表药学领域等方向的原创性研究为核心(研究类文章占比85.29%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在34篇,确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Cardiovascular Therapeutics审稿周期约为 约6月 。该刊近年未被列入国际预警名单,年发文量约34篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCIE 期刊收录
  • 34 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
4区
PHARMACOLOGY & PHARMACY 药学 CARDIAC & CARDIOVASCULAR SYSTEMS 心脏和心血管系统
3区 4区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
4区
CARDIAC & CARDIOVASCULAR SYSTEMS 心脏和心血管系统 PHARMACOLOGY & PHARMACY 药学
4区 4区

JCR分区

按JIF指标学科分区 收录子集 分区 排名 百分位
学科:CARDIAC & CARDIOVASCULAR SYSTEMS SCIE Q2 57 / 220

74.3%

学科:PHARMACOLOGY & PHARMACY SCIE Q2 105 / 354

70.5%

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:CARDIAC & CARDIOVASCULAR SYSTEMS SCIE Q2 69 / 220

68.86%

学科:PHARMACOLOGY & PHARMACY SCIE Q2 125 / 354

64.83%

CiteScore

CiteScore SJR SNIP CiteScore 排名
CiteScore:5.6 SJR:0.769 SNIP:0.723
学科类别 分区 排名 百分位
大类:Medicine 小类:Cardiology and Cardiovascular Medicine Q1 95 / 387

75%

大类:Medicine 小类:Pharmacology (medical) Q2 87 / 272

68%

大类:Medicine 小类:Pharmacology Q2 133 / 313

57%

期刊发文

  • Effect of Mini-Tyrosyl-tRNA Synthetase/Mini-Tryptophanyl-tRNA Synthetase on Angiogenesis in Rhesus Monkeys after Acute Myocardial Infarction.

    Author: Zeng R, Wang M, You GY, Yue RZ, Chen YC, Zeng Z, Liu R, Qiang O, Zhang L.

    Journal: Cardiovasc Ther. 2016 Feb;34(1):4-12. doi: 10.1111/1755-5922.12161.

  • Aspirin Attenuates Angiotensin II-induced Cardiomyocyte Hypertrophy by Inhibiting the Ca(2+)/Calcineurin-NFAT Signaling Pathway.

    Author: Yin Z, Wang X, Zhang L, Zhou H, Wei L, Dong X.

    Journal: Cardiovasc Ther. 2016 Feb;34(1):21-9. doi: 10.1111/1755-5922.12164.

  • Bioinformatics Analyses of Differentially Expressed Genes Associated with Acute Myocardial Infarction.

    Author: Gao Y, Qi GX, Guo L, Sun YX.

    Journal: Cardiovasc Ther. 2016 Apr;34(2):67-75. doi: 10.1111/1755-5922.12171.

  • Non-vitamin K Oral Anticoagulants Versus Warfarin for Patients with Atrial Fibrillation: Absolute Benefit and Harm Assessments Yield Novel Insights.

    Author: Kumana CR, Cheung BM, Siu DC, Tse HF, Lauder IJ.

    Journal: Cardiovasc Ther. 2016 Apr;34(2):100-6. doi: 10.1111/1755-5922.12173. Review.

  • The Importance of the Mean Platelet Aggregation Degree in Long-term Dual Antiplatelet Therapy Following Drug-Eluting Stent Implantation.

    Author: Li Q, Ren X, Yu X, He J, Gao Y, Zhang X, Wu C, Luo Y, Zhang Y, Chen F.

    Journal: Cardiovasc Ther. 2016 Jun;34(3):127-37. doi: 10.1111/1755-5922.12177.

  • Autonomic Modulation by Electrical Stimulation of the Parasympathetic Nervous System: An Emerging Intervention for Cardiovascular Diseases.

    Author: He B, Lu Z, He W, Huang B, Jiang H.

    Journal: Cardiovasc Ther. 2016 Jun;34(3):167-71. doi: 10.1111/1755-5922.12179. Review.

  • Increased Serum Level of Growth Differentiation Factor 15 (GDF-15) is Associated with Coronary Artery Disease.

    Author: Wang X, Chen LL, Zhang Q.

    Journal: Cardiovasc Ther. 2016 Jun;34(3):138-43. doi: 10.1111/1755-5922.12184.

  • Influence of APOE gene polymorphism on interindividual and interethnic warfarin dosage requirement: A systematic review and meta analysis.

    Author: Wan-Ying Y, Xue S, Wadelius M, Lihua H, Peng C, Wan-le M, Yang GP.

    Journal: Cardiovasc Ther. 2016 Apr 6. doi: 10.1111/1755-5922.12186. [Epub ahead of print]